Rational requesting or rationing testing?
作者信息
Lock R J
出版信息
J Clin Pathol. 2004 Feb;57(2):121-2. doi: 10.1136/jcp.2003.11122.
Abstract
摘要
相似文献
1
Rational requesting or rationing testing?
J Clin Pathol. 2004 Feb;57(2):121-2. doi: 10.1136/jcp.2003.11122.
2
The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.
J Clin Pathol. 2004 Feb;57(2):131-4. doi: 10.1136/jcp.2003.8052.
3
ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.
J Clin Pathol. 2000 Aug;53(8):644-5. doi: 10.1136/jcp.53.8.644.
4
Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital.
J Clin Pathol. 2009 Aug;62(8):743-5. doi: 10.1136/jcp.2009.064485.
5
Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
J Clin Pathol. 2010 Aug;63(8):678-80. doi: 10.1136/jcp.2009.072504.
6
Anti-neutrophil autoantibodies and systemic vasculitis: a report of five cases.
Acta Paediatr. 1997 Apr;86(4):438-9. doi: 10.1111/j.1651-2227.1997.tb09040.x.
7
Interpretation of ANCA serology.
N Z Med J. 1999 Mar 12;112(1083):65-6.
8
Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in an elderly woman.
Can Fam Physician. 2016 Aug;62(8):635-7.
9
[Use of clinical tests to detect anti-neutrophil cytoplasmic antibodies in vasculitis].
Pol Arch Med Wewn. 2001;105 Suppl:41-2.
10
Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Int J Rheum Dis. 2017 Jun;20(6):774-778. doi: 10.1111/1756-185X.12926. Epub 2016 Jul 26.
引用本文的文献
1
A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases.
Rheumatol Int. 2009 May;29(7):849-51. doi: 10.1007/s00296-008-0783-5. Epub 2008 Nov 22.
本文引用的文献
1
The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.
J Clin Pathol. 2004 Feb;57(2):131-4. doi: 10.1136/jcp.2003.8052.
2
Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.
Rheumatology (Oxford). 2003 Feb;42(2):223-9. doi: 10.1093/rheumatology/keg066.
3
Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?
Arch Intern Med. 2002 Jul 8;162(13):1509-14. doi: 10.1001/archinte.162.13.1509.
4
Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.
Clin Exp Dermatol. 2002 Jan;27(1):59-61. doi: 10.1046/j.0307-6938.2001.00964.x.
5
The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting.
QJM. 2001 Nov;94(11):615-21. doi: 10.1093/qjmed/94.11.615.
6
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.
Am J Gastroenterol. 2001 Mar;96(3):758-65. doi: 10.1111/j.1572-0241.2001.03618.x.
7
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Am J Gastroenterol. 2001 Feb;96(2):449-54. doi: 10.1111/j.1572-0241.2001.03524.x.
8
Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
Curr Gastroenterol Rep. 1999 Dec;1(6):482-5. doi: 10.1007/s11894-999-0007-5.
9
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.
Kidney Int. 2000 Mar;57(3):846-62. doi: 10.1046/j.1523-1755.2000.057003846.x.
10
Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?
Scand J Gastroenterol. 1999 Nov;34(11):1123-31. doi: 10.1080/003655299750024931.
Zotero 插件